obeticholic-acid and Colitis

Glucocorticoids (GCs) are important endocrine regulators of a wide range of physiological processes ranging from immune function to glucose and lipid metabolism. For decades, synthetic glucocorticoids such as dexamethasone have been the cornerstone for the clinical treatment of inflammatory bowel diseases (IBD). A previous study has shown that farnesoid X receptor (FXR) enhances the transcription of NR3C1 gene, which encodes for human GR, by binding to a conserved FXR response element (FXRE) in the distal promoter of this gene. In the present study we demonstrate that FXR promotes the resolution of colitis in rodents by enhancing Gr gene transcription. We used the chromatin conformation capture (3C) assay to demonstrate that this FXRE is functional in mediating a head-to-tail chromatin looping, thus increasing Gr transcription efficiency. These findings underscore the importance of FXR/GR axis in the control of intestinal inflammation.

Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chenodeoxycholic Acid; Chromatin; Colitis; Dexamethasone; Humans; Mice; Mice, Knockout; Mifepristone; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Glucocorticoid; Response Elements; Trinitrobenzenesulfonic Acid